"Mitoguazone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase.
| Descriptor ID |
D008935
|
| MeSH Number(s) |
D02.078.370.600
|
| Concept/Terms |
Mitoguazone- Mitoguazone
- MGBG
- Methylglyoxal Bis(guanylhydrazone)
|
Below are MeSH descriptors whose meaning is more general than "Mitoguazone".
Below are MeSH descriptors whose meaning is more specific than "Mitoguazone".
This graph shows the total number of publications written about "Mitoguazone" by people in this website by year, and whether "Mitoguazone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mitoguazone" by people in Profiles.
-
Synergistic effect of sequential administration of mitoguazone (MGBG) and gemcitabine in treating tissue cultured human breast cancer cells and mammary rat tumors. Cancer Invest. 2003 Apr; 21(2):217-26.
-
A phase I human trial of mitoguazone and gemcitabine sequential bi-weekly treatment of cancer patients. Cancer Invest. 2003; 21(4):542-9.